openPR Logo
Press release

Nano Chemotherapy Market Nano Chemotherapy Clinical Pipeline Report 2022

07-11-2017 09:50 AM CET | Health & Medicine

Press release from: Kuick Resarch

Nano Chemotherapy Market Nano Chemotherapy Clinical Pipeline

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

Report Table of Contents

Nano Chemotherapeutics Mediations andndash; Solicitation to Nanomedicine
1.1 Overview
1.2 Nano Chemotherapeutics with Pharmaceutical Potential

Significance of Nano Chemotherapeutics to overcome the Chemotherapy Limitations
2.1 Limitations of Conventional Chemotherapy
2.2 Nanotechnology in Cancer Targeting
2.2.1 Active Targeting
2.2.2 Passive Targeting
2.2.3 pH Dependent Drug Delivery Through Nanoparticles

Role of Nanotherapeutics in Various Diseases Treatment
3.1 Nanotherapeutics Approach for Cardiovascular Disease
3.2 Nanotherapeutics Approach for Cancer Therapy
3.3 Nanotherapeutics Approach for Diabetes Treatment
3.4 Nanotherapeutics Approach for Rheumatoid Arthritis

Chemotherapeutics Nanoformulations of Approved Drugs: Clinical Insights and Price Analysis
4.1 Abraxane (Advanced Lung, Pancreatic, Breast Cancers)
4.2 Depocyte (Lymphomtous Meningitis)
4.3 Doxil (Kaposi’s Sarcoma, Ovarian Cancer)
4.4 Marqibo (Acute Myelogenous Leukemia)
4.5 Neulasta (Chemotherapy Induced Neutropenia)
4.6 Oncospar (Acute Lymphoblastic Leukemia)
4.7 Zevalin (Non-Hodgkin Lymphoma)

Chemotherapeutics Nanoformulations in Clinical Trials: Clinical Insight and Mode of Action
5.1 MM-302 (Metastatic Breast Cancer)
5.2 Thermodox (Hepatobiliary Tumors)
5.3 CPX-351 (Acute Myelogenous Leukemia)
5.4 IHL-305 (Solid Tumor Malignancy)
5.5 MM-398 (Metastatic Pancreatic Cancer)
5.6 BIND-014 (Metastatic Prostate Cancer)
5.7 NK-012 (Solid Tumor Malignancy)
5.8 CRLX-101 (Solid Tumor Malignancy and Rectal Cancer)

Global Market Nanotherapeutics Outlook
6.1 Market Scenario of Nanotherapeutics
6.2 Market Size of Nanomedicine

Cancer Nanotherapeutics Market Revenue
7.1 Sales of Nano Chemotherapeutic Drugs
7.2 Top Nanotherapeutics Companies Revenue
7.3 Global Cancer Nanomedicine Clinical Pipeline Overview

Global Nano Chemotherapeutics Market Dynamics
8.1 Favorable Parameters
8.2 Challenges to the Market Growth

Future Perceptive of Nano Chemotherapeutics

Competitive Landscape
10.1 Ablynx
10.2 AMAG
10.3 Amgen
10.4 Celgene
10.5 CytImmune
10.6 Cornerstone
10.7 Delpor
10.8 Ensysce
10.9 MagForce AG
10.10 Merrimack
10.11 Nanotherapeutics
10.12 Nanobiotix
10.13 Nanospectra
10.14 Spectrum pharmaceuticals
10.15 Tarveda

Download Report: https://www.kuickresearch.com/report-global-nano-chemotherapy-market-and-clinical-trials-outlook-2022.php

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nano Chemotherapy Market Nano Chemotherapy Clinical Pipeline Report 2022 here

News-ID: 618370 • Views: 516

More Releases from Kuick Resarch

Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024
"Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024" Report Highlights: • Commutative Market Opportunity During Initial 5 years of Commercialization: > US$ 2 Billion • Trispecific Antibodies In Clinical Trials: > 8 Antibodies • Highest Phase of Development: Phase I/II • Cancer Dominating Trispecific Antibodies Trials: > 5 Antibodies • Numab Therapeutics Dominating the Trispecific Development Pipeline • Prevention & Second Line Therapy Key Focus of Development of Trispecific Antibodies Download Report: https://www.kuickresearch.com/report-global-trispecific-antibodies-antibody-market-sales-size-companies-cancer-trispecific--clinical-trials-sar441236--development-conjugate-immunogenicity Trispecific cancer antibody therapy market at
Global BiTE Antibodies Market, Price, Sales & Clinical Trials Insight 2025
"Global BiTE Antibodies Market, Price, Sales & Clinical Trials Insight 2025" Report Highlights: • Global BiTE Antibody Market Opportunity Insight (2021-2025) • Currently Only 1 BiTE Commercially Available In Market: Blinatumomab (Blincyto) • Blincyto Dosage & Market Sales Analysis ( Yearly, Quarterly & Regional Sales) • Global BiTE Antibody Clinical Trials Indicators by Phase, Company, Country, Indication & Patient Segment • Global Bispecific T-Cell Engagers Market Dynamics Download Report: https://www.kuickresearch.com/report-global-bite-antibodies-blinatumomab-antibody-immunology-anticancer-market-sales-size-growth-forecast-price-cost-amgen-bispecific-t-cell-engager The research report, "Global BiTE Antibodies Market , Price, Sales &
Global BCL-2 (B Cell Lymphoma 2) Inhibitors Market & Clinical Trials Insight 202 …
"Global BCL-2 (B Cell Lymphoma 2) Inhibitors Market & Clinical Trials Insight 2025" Report Highlights: • Global BCL-2 Inhibitors Market Opportunity: >US$ 4 Billion by 2025 • Insight on Market Indicators & Approved Drugs Sales Data • Global BCL-2 Inhibitors Market Absolute Growth: >300% ( 97% CAGR, 2018 - 2020) • Comprehensive Information On Ongoing Clinical Trials • Global BCL-2 inhibitors Clinical Trials By Company, Indication & Phase • Venetoclax Is The First Approved Drug Belonging To The Class Of BCL2
Global Antibody Drug Conjugate Market Sales Size Opportunity To Surpass US$ 10 B …
"Novel Cancer Antibody Drug Conjugates to Drive Cancer Therapeutics Market With More Than 290 Cancer Antibodies In Clinical Trials Pipeline Says Kuick Research" "Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Antibody Drug Conjugate (ADC) Pipeline: 297 Drugs • Marketed Cancer Antibody Drug Conjugate: 9 Drugs • Antibody Drug Conjugate Marketed Opportunity: > US$ 13 Billion By 2026 • Majority of Drug Trials Are For Second Line Therapy

All 5 Releases


More Releases for Nano

Nano UAV Global Information 2019
Press Release – 29 Jan 2019 Research and Development News -- . . Latest Update "Global Nano UAV Market Research Report 2019" with Industries Survey | Global Current Growth and Future. ' ' The global Nano UAV market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nano UAV volume and value at global level,
ZOTAC Releases New ZBOX nano ID67 Series
Dubai, UAE – Jan. 14, 2014 – ZOTAC International, a global innovator and manufacturer of graphics cards, mainboards, mini-PCs and accessories, today releases the new ZBOX nano ID67 series with 4th Generation Intel Core technology. The new ZOTAC ZBOX nano ID67 series incorporates the latest Intel Core i3 4010U processor for great day-to-day performance and excellent energy efficiency. “Our engineers continue to boost performance of our ZBOX mini-PCs. The latest ZBOX
NANO MEETS TEMPERATURE SENSOR
FIBEROPTIC NANO TEMPERATURE SENSOR AND NANO-KIT Fiber optic temperature sensors from different manufacturers typically use especially prepared fiberglass for temperature measurement. These fiber tips consist of gallium arsenide (GaAs) crystals. This type of sensor is very expensive to produce and mechanically sensitive to impact. The good news is: The fiber optic temperature sensors from Optocon AG are also available in a nano-powder version. Bound nano scaled GaAs powder adhesive, replaces the previous GaAs
Nano-Positioning equipment with highest positioning accuracy
Newly designed piezo-positioning stage with smaller dimensions and travel range extension! piezosystem jena is pleased to present, the piezo-electric nano positioning stage, and newly advanced design of the PX 100 CAP. Without compromising the excellent accuracy, the travel range has been extended up to 100µm of motion in closed loop mode. For positioning control a high resolution capacitive feedback sensor is built in. The sensor is able to measure a deviation of
Nano Med Tech Hires Stateside Sales Team
Nano Med Tech, a newly emerging leader in nano-technological cancer research and treatment, announced that its sales team for America is in place and that stateside medical marketing will commence, soon. With a Commercial Director and eight account managers in place, Nano Med Tech will now seek to make its technology available in medical institutions throughout the United States. The organization has received USFDA approval for several patented medical devices, which utilize advanced
New dynamic nano positioner PX 50 CAP
piezosystem jena, a world leading company in the development, design and engineering of piezo electrical actuator based positioning systems for micro- and nanopositioning, now introduces a new positioner. The PX 50 CAP expands the PX series, which has been established for years. This nano positioner provides a travel of 50 microns. Due to a special mechanical FEM-optimized design the actuator has the highest dynamical features that can be generated.